Advertisement
Screener

SIONNA THERAPEUTICS, INC. (SION) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SIONNA THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where SIONNA THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $66.30M went out.
  • Fiscal year ended 2025-12-31: from investing, $118.75M went out.
  • Fiscal year ended 2025-12-31: from financing, $205.71M came in.
  • Fiscal year ended 2025-12-31: change in cash, $20.66M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$66.30M-$118.75M$3.64M$202.07M*$20.66M
2024-12-31-$52.79M-$126.91M$141.00K$178.83M*-$733.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$22.22M*$21.47M*$979.00K*
2026-03-31-$21.84M$24.82M$2.21M$4.87M
2025-12-31-$16.63M*$22.59M*$1.66M*
2025-09-30-$15.23M*$23.10M*$1.97M*
2025-06-30-$18.15M*-$23.25M*$6.00K*
2025-03-31-$16.29M-$141.19M$0.00$202.39M*$44.91M
2024-12-31-$11.78M*$15.23M*$25.00K*-$1.43M*
2024-09-30-$17.69M*$10.41M*$73.00K*-$1.07M*
2024-06-30-$10.14M*-$28.62M*$38.00K*
2024-03-31-$13.18M-$123.93M$5.00K$181.33M*$44.23M

Similar stocks

Stock NameCountryMarket CapPE Ratio
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Pyxis Oncology, Inc. (PYXS)United States$0.244B
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32